Education
About Us
Working with TipRanks
Follow Us
Tao Synergies (TAOX)
NASDAQ:TAOX
TAOX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.84 - $11.98
Previous CloseN/A
VolumeN/A
Average Volume (3M)373.91K
Market Cap
$15.18M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.80
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,328,690
10 Day Avg. Volume317,988
30 Day Avg. Volume373,913
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tao Synergies News
TAOX FAQ
What was Tao Synergies’s price range in the past 12 months?
Tao Synergies lowest stock price was $1.84 and its highest was $11.98 in the past 12 months.
What is Tao Synergies’s market cap?
Tao Synergies’s market cap is $15.18M.
When is Tao Synergies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tao Synergies’s earnings last quarter?
Currently, no data Available
Is Tao Synergies overvalued?
According to Wall Street analysts Tao Synergies’s price is currently Overvalued.
Does Tao Synergies pay dividends?
Tao Synergies does not currently pay dividends.
What is Tao Synergies’s EPS estimate?
Tao Synergies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tao Synergies have?
Tao Synergies has 2,328,690 shares outstanding.
What happened to Tao Synergies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tao Synergies?
Currently, no hedge funds are holding shares in TAOX
Company Description
Tao Synergies
Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.
Tao Synergies (TAOX) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Matinas BioPharma
―
Enveric Biosciences
―
CNS Pharmaceuticals
―
Galecto
―
NLS Pharmaceutics
―
Ownership Overview
5.87%
Insiders
0.96%
Mutual Funds
<0.01% Other Institutional Investors
92.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---